Market Research Logo

AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virology and metabolic therapy areas. The company also offers medicines for neurological disorders and other serious health conditions. AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies. The company its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Jul 27,2018: AbbVie Reports Second-Quarter 2018 Financial Results
Jul 18,2018: AbbVie signs patent licensing deal with Mylan over Humira biosimilar
Jul 06,2018: Judge strikes $140M AndroGel verdict after AbbVie appeal
May 23,2018: Big Pharma CMOs Win for Biologic API and Alcami Scores Highest for Biologic Drug Product
May 22,2018: AbbVie Donates $100 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
AbbVie Inc - Key Facts
AbbVie Inc - Key Employees
AbbVie Inc - Key Employee Biographies
AbbVie Inc - Major Products and Services
AbbVie Inc - History
AbbVie Inc - Company Statement
AbbVie Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AbbVie Inc - Business Description
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: All other countries
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The UK
Performance
Geographical Segment: United States
Performance
R&D Overview
AbbVie Inc - Corporate Strategy
AbbVie Inc - SWOT Analysis
SWOT Analysis - Overview
AbbVie Inc - Strengths
AbbVie Inc - Weaknesses
AbbVie Inc - Opportunities
AbbVie Inc - Threats
AbbVie Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AbbVie Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 27, 2018: AbbVie Reports Second-Quarter 2018 Financial Results
Jul 18, 2018: AbbVie signs patent licensing deal with Mylan over Humira biosimilar
May 23, 2018: Big Pharma CMOs Win for Biologic API and Alcami Scores Highest for Biologic Drug Product
May 22, 2018: AbbVie Donates $100 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico
May 16, 2018: AbbVie to Show Progress and Growth in Oncology Research at the American Society of Clinical Oncology 2018 Annual Meeting
Apr 30, 2018: AbbVie and Rice University establish K.C. Nicolaou Research Accelerator to advance therapies in oncology
Apr 26, 2018: AbbVie Reports First-Quarter 2018 Financial Results
Mar 28, 2018: AbbVie pays $5m to man who claims testosterone drug caused heart attack
Mar 28, 2018: AbbVie pays $5m to man who claims testosterone drug caused heart attack
Mar 21, 2018: AbbVie and the International Myeloma Foundation Announce Partnership to Study the Role of a Genetic Mutation in Outcomes of Patients with Multiple Myeloma
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont...1)
AbbVie Inc, Annual Ratios (Cont...2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AbbVie Inc, Performance Chart (2013 - 2017)
AbbVie Inc, Ratio Charts
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AbbVie Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report